HBK Investments’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-99,100
Closed -$6.93M 556
2022
Q1
$6.93M Sell
99,100
-78,600
-44% -$5.75M 0.03% 189
2021
Q4
$13.8M Hold
177,700
0.05% 91
2021
Q3
$17M Sell
177,700
-7,600
-4% -$802K 0.07% 74
2021
Q2
$23M Sell
185,300
-8,800
-5% -$1.05M 0.08% 77
2021
Q1
$25.6M Buy
194,100
+17,000
+10% +$2.33M 0.12% 57
2020
Q4
$23.5M Sell
177,100
-37,400
-17% -$4.52M 0.15% 61
2020
Q3
$21.9M Buy
214,500
+64,500
+43% +$5.57M 0.16% 52
2020
Q2
$13M Buy
+150,000
New +$12M 0.17% 72

Other funds holding EXAS

HBK Investments's EXAS Position: Q1 2026 in Review

HBK Investments sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 7,646,637 shares — an estimated $777M sold.

HBK Investments first reported a position in EXAS in Q3 2013 and held it in 7 quarters. The position peaked at $777M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • HBK Investments reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • HBK Investments sold 7,646,637 Exact Sciences shares in Q1 2026, an estimated $777M.
  • HBK Investments first reported a position in Exact Sciences in Q3 2013 and held it in 7 quarters.
  • HBK Investments's Exact Sciences position peaked at $777M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on HBK Investments's 13F filing for Q1 2026, filed 15 May 2026.